Craig C. Hopkinson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Craig C. Hopkinson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Craig C. Hopkinson. Craig C. Hopkinson is EVP R&D, Chief Medical Officer in Alkermes plc. ($ALKS) and SVP, Med Dev/Med Affairs, CMO in Alkermes plc. ($ALKS).
Latest Insider Trading Transactions of Craig C. Hopkinson
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | M | 0.00 | 1,250 | 0 | 0 | |
| Jun 08 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Payment of Exercise | F | 23.50 | 368 | 8,648 | 882 | 1.3 K to 882 (-29.44 %) |
| Jun 08 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Buy | M | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Apr 16 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Sell | S | 19.72 | 28,920 | 570,288 | 0 | 28.9 K to 0 (-100.00 %) |
| Feb 24 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | A | 0.00 | 48,151 | 0 | 48,151 | |
| Feb 24 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | A | 19.73 | 196,484 | 3,876,629 | 196,484 | |
| Feb 23 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | M | 0.00 | 6,875 | 0 | 13,750 | |
| Feb 23 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | M | 0.00 | 10,095 | 0 | 30,287 | |
| Feb 23 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Payment of Exercise | F | 19.58 | 2,022 | 39,591 | 28,920 | 30.9 K to 28.9 K (-6.53 %) |
| Feb 23 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Buy | M | 0.00 | 6,875 | 0 | 30,942 | 24.1 K to 30.9 K (+28.57 %) |
| Feb 23 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Payment of Exercise | F | 19.58 | 3,064 | 59,993 | 24,067 | 27.1 K to 24.1 K (-11.29 %) |
| Feb 23 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Buy | M | 0.00 | 10,095 | 0 | 27,131 | 17 K to 27.1 K (+59.26 %) |
| Feb 18 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | M | 0.00 | 3,375 | 0 | 3,375 | |
| Feb 18 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Payment of Exercise | F | 19.79 | 1,172 | 23,194 | 17,036 | 18.2 K to 17 K (-6.44 %) |
| Feb 18 2021 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Buy | M | 0.00 | 3,375 | 0 | 18,208 | 14.8 K to 18.2 K (+22.75 %) |
| Jun 08 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | M | 0.00 | 1,250 | 0 | 1,250 | |
| Jun 08 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Payment of Exercise | F | 17.19 | 368 | 6,326 | 14,833 | 15.2 K to 14.8 K (-2.42 %) |
| Jun 08 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Buy | M | 0.00 | 1,250 | 0 | 15,201 | 14 K to 15.2 K (+8.96 %) |
| Feb 24 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | M | 32.57 | 6,875 | 223,919 | 99,825 | |
| Feb 24 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | A | 0.00 | 40,382 | 0 | 40,382 | |
| Feb 24 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | A | 20.43 | 168,856 | 3,449,728 | 168,856 | |
| Feb 24 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Payment of Exercise | F | 20.24 | 2,004 | 40,561 | 13,951 | 16 K to 14 K (-12.56 %) |
| Feb 24 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Buy | M | 0.00 | 6,875 | 0 | 15,955 | 9.1 K to 16 K (+75.72 %) |
| Feb 18 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Option Exercise | M | 0.00 | 3,375 | 0 | 6,750 | |
| Feb 18 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Payment of Exercise | F | 17.77 | 1,172 | 20,826 | 9,080 | 10.3 K to 9.1 K (-11.43 %) |
| Feb 18 2020 | ALKS | Alkermes plc. | Hopkinson Craig C. | EVP R&D, Chief Medi ... | Buy | M | 0.00 | 3,375 | 0 | 10,252 | 6.9 K to 10.3 K (+49.08 %) |
| Jun 10 2019 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Option Exercise | M | 0.00 | 1,250 | 0 | 2,500 | |
| Jun 10 2019 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Payment of Exercise | F | 22.83 | 368 | 8,401 | 6,877 | 7.2 K to 6.9 K (-5.08 %) |
| Jun 10 2019 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Buy | M | 0.00 | 1,250 | 0 | 7,245 | 6 K to 7.2 K (+20.85 %) |
| Feb 25 2019 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Option Exercise | A | 0.00 | 27,500 | 0 | 27,500 | |
| Feb 25 2019 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Option Exercise | A | 32.57 | 106,700 | 3,475,219 | 106,700 | |
| Feb 19 2019 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Option Exercise | M | 0.00 | 3,375 | 0 | 10,125 | |
| Feb 19 2019 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Payment of Exercise | F | 32.54 | 1,083 | 35,241 | 5,995 | 7.1 K to 6 K (-15.30 %) |
| Feb 19 2019 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Buy | M | 0.00 | 3,375 | 0 | 7,078 | 3.7 K to 7.1 K (+91.14 %) |
| Dec 11 2018 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Payment of Exercise | F | 34.01 | 1,178 | 40,064 | 3,703 | 4.9 K to 3.7 K (-24.13 %) |
| Dec 11 2018 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Grant | A | 0.00 | 4,000 | 0 | 4,881 | 881 to 4.9 K (+454.03 %) |
| Jun 08 2018 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
| Jun 08 2018 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Payment of Exercise | F | 48.30 | 369 | 17,823 | 881 | 1.3 K to 881 (-29.52 %) |
| Jun 08 2018 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Buy | M | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Feb 21 2018 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Option Exercise | A | 67.26 | 54,500 | 3,665,670 | 54,500 | |
| Feb 21 2018 | ALKS | Alkermes plc. | Hopkinson Craig C. | SVP, Med Dev/Med Af ... | Option Exercise | A | 0.00 | 13,500 | 0 | 13,500 |
Page: 1